Abstract

Besides the standard parameters used for colorectal cancer (CRC) management, new features are needed in clinical practice to improve progression-free and overall survival. In some cancers, the microenvironment mechanical properties can contribute to cancer progression and metastasis formation, or constitute a physical barrier for drug penetration or immune cell infiltration. These mechanical properties remain poorly known for colon tissues. Using a multidisciplinary approach including clinical data, physics and geostatistics, we characterized the stiffness of healthy and malignant colon specimens. For this purpose, we analyzed a prospective cohort of 18 patients with untreated colon adenocarcinoma using atomic force microscopy to generate micrometer-scale mechanical maps. We characterized the stiffness of normal epithelium samples taken far away or close to the tumor area and selected tumor tissue areas. These data showed that normal epithelium was softer than tumors. In tumors, stroma areas were stiffer than malignant epithelial cell areas. Among the clinical parameters, tumor left location, higher stage, and RAS mutations were associated with increased tissue stiffness. Thus, in patients with CRC, measuring tumor tissue rigidity may have a translational value and an impact on patient care.

Details

Title
Mechanical signatures of human colon cancers
Author
Lopez-Crapez, Evelyne 1 ; Costa, Luca 2 ; Tosato, Guillaume 3 ; Ramos, Jeanne 4 ; Mazard, Thibault 5 ; Guiramand, Janique 6 ; Thierry, Alain 7 ; Colinge, Jacques 7 ; Milhiet, Pierre-Emmanuel 2 ; Bénistant, Christine 2 

 Institut Régional du Cancer Montpellier (ICM), Montpellier, France (GRID:grid.418189.d) (ISNI:0000 0001 2175 1768); Université de Montpellier, Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141); Unité de Recherche Translationnelle, Institut du Cancer de Montpellier (ICM), Montpellier, France (GRID:grid.418189.d) (ISNI:0000 0001 2175 1768) 
 Université de Montpellier, Centre de Biologie Structurale (CBS), CNRS, INSERM, Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141) 
 Université de Montpellier, Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141); Centre Hospitalier Universitaire (CHU) Lapeyronie, Montpellier, France (GRID:grid.157868.5) (ISNI:0000 0000 9961 060X) 
 Institut Régional du Cancer Montpellier (ICM), Montpellier, France (GRID:grid.418189.d) (ISNI:0000 0001 2175 1768); Unité de Recherche Translationnelle, Institut du Cancer de Montpellier (ICM), Montpellier, France (GRID:grid.418189.d) (ISNI:0000 0001 2175 1768) 
 Institut Régional du Cancer Montpellier (ICM), Montpellier, France (GRID:grid.418189.d) (ISNI:0000 0001 2175 1768); Université de Montpellier, Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141) 
 Université de Montpellier, ENSCM, Institut des Biomolécules Max Mousseron (IBMM), UMR5247 CNRS, Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141) 
 Université de Montpellier, Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2692490073
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.